Literature DB >> 22678518

Levels of non enzymatic antioxidants in Down syndrome.

S Mehar Sulthana1, S Nandha Kumar, M G Sridhar, B Vishnu Bhat, K Ramachandra Rao.   

Abstract

OBJECTIVES: To confirm the clinical diagnosis of Down syndrome by chromosomal analysis and to explore the oxidative stress in children with Down syndrome by estimating the levels of non enzymatic antioxidants like reduced glutathione(GSH) and total antioxidants status (TAS).
METHODS: The study included 31 clinically diagnosed children with Down syndrome with equal number of age and sex matched controls. Trisomy 21 was confirmed by conventional lymphocyte cell culture. Erythrocytic reduced glutathione (GSH) and plasma total antioxidant status (TAS) were measured sphectrophotometrically.
RESULTS: The levels of erythrocytic reduced glutathione (GSH) and plasma total antioxidant status (TAS) were significantly reduced in children with Down syndrome.
CONCLUSIONS: Children with Down syndrome have elevated levels of oxidative stress . Hence antioxidant therapy can be beneficial among them.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22678518     DOI: 10.1007/s12098-012-0795-8

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  9 in total

1.  Improved method for the determination of blood glutathione.

Authors:  E BEUTLER; O DURON; B M KELLY
Journal:  J Lab Clin Med       Date:  1963-05

2.  The redox state of glutathione in erythrocytes of individuals with Down syndrome.

Authors:  J Muchova; I Garaiova; M Sustrova; A Liptakova; P Blazicek; P Kvasnicka; Z Durackova
Journal:  Bratisl Lek Listy       Date:  2007       Impact factor: 1.278

Review 3.  Oxidative stress: oxidants and antioxidants.

Authors:  H Sies
Journal:  Exp Physiol       Date:  1997-03       Impact factor: 2.969

4.  Effect of vitamin E on chromosomal aberrations in lymphocytes from patients with Down's syndrome.

Authors:  J Pincheira; M H Navarrete; C de la Torre; G Tapia; M J Santos
Journal:  Clin Genet       Date:  1999-03       Impact factor: 4.438

5.  Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality.

Authors:  Edgar R Miller; Roberto Pastor-Barriuso; Darshan Dalal; Rudolph A Riemersma; Lawrence J Appel; Eliseo Guallar
Journal:  Ann Intern Med       Date:  2004-11-10       Impact factor: 25.391

Review 6.  Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis.

Authors:  Goran Bjelakovic; Dimitrinka Nikolova; Lise Lotte Gluud; Rosa G Simonetti; Christian Gluud
Journal:  JAMA       Date:  2007-02-28       Impact factor: 56.272

7.  The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay.

Authors:  I F Benzie; J J Strain
Journal:  Anal Biochem       Date:  1996-07-15       Impact factor: 3.365

8.  Multiple evidence for an early age pro-oxidant state in Down Syndrome patients.

Authors:  Federico V Pallardó; Paolo Degan; Marco d'Ischia; Frank J Kelly; Adriana Zatterale; Rita Calzone; Giuseppe Castello; Rafael Fernandez-Delgado; Christina Dunster; Ana Lloret; Paola Manini; Maria Antonietta Pisanti; Emilia Vuttariello; Giovanni Pagano
Journal:  Biogerontology       Date:  2006-04-13       Impact factor: 4.277

9.  Supplementation with antioxidants and folinic acid for children with Down's syndrome: randomised controlled trial.

Authors:  Jill M Ellis; Hooi Kuan Tan; Ruth E Gilbert; David P R Muller; William Henley; Robert Moy; Rachel Pumphrey; Cornelius Ani; Sarah Davies; Vanessa Edwards; Heather Green; Alison Salt; Stuart Logan
Journal:  BMJ       Date:  2008-02-21
  9 in total
  4 in total

Review 1.  The genomically mosaic brain: aneuploidy and more in neural diversity and disease.

Authors:  Diane M Bushman; Jerold Chun
Journal:  Semin Cell Dev Biol       Date:  2013-03-04       Impact factor: 7.727

2.  Oxidative Stress -a Phenotypic Hallmark of Fanconi Anemia and Down Syndrome: The Effect of Antioxidants.

Authors:  H T El-Bassyouni; H H Afifi; M M Eid; R M Kamal; H H El-Gebali; Gsm El-Saeed; M M Thomas; S A Abdel-Maksoud
Journal:  Ann Med Health Sci Res       Date:  2015 May-Jun

Review 3.  Peripheral Oxidation Markers in Down Syndrome Patients: The Better and the Worse.

Authors:  Dominik Szwajgier; Ewa Baranowska-Wójcik; Joanna Grzelczyk; Wioletta Żukiewicz-Sobczak
Journal:  Dis Markers       Date:  2021-06-28       Impact factor: 3.434

Review 4.  Cancer metabolism and oxidative stress: Insights into carcinogenesis and chemotherapy via the non-dihydrofolate reductase effects of methotrexate.

Authors:  Joshua A Hess; Mohamad K Khasawneh
Journal:  BBA Clin       Date:  2015-02-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.